Medical Device | May 08, 2026
Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
Certification reinforces energy efficiency, sustainability goals, and green manufacturing across SMT’s Surat and Hyderabad facilities
Approval for generic Semaglutide Injection strengthens CDMO partnership, enabling scalable supply from OneSource’s US FDA-approved Bengaluru facility
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
PMDA is regarded among the most stringent regulatory bodies globally
Subscribe To Our Newsletter & Stay Updated
